Bradycor bradykinin antagonist: IND to begin Phase II testing

Cortech Inc. (CRTQ), Denver Product: Bradycor bradykinin antagonist Indication: Multiple trauma Status: The company filed a fourth amendment to its IND to begin Phase II testing in up to 140 patients...